Poniard Pharmaceuticals Stock Profit Margin
Poniard Pharmaceuticals fundamentals help investors to digest information that contributes to Poniard Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Poniard Pink Sheet. The fundamental analysis module provides a way to measure Poniard Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Poniard Pharmaceuticals pink sheet.
Poniard |
Poniard Pharmaceuticals Company Profit Margin Analysis
Poniard Pharmaceuticals' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Poniard Pharmaceuticals has a Profit Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Poniard Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Poniard Pharmaceuticals' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Poniard Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Poniard Pharmaceuticals by comparing valuation metrics of similar companies.Poniard Pharmaceuticals is currently under evaluation in profit margin category among its peers.
Poniard Fundamentals
| Return On Equity | -2.1 | ||||
| Return On Asset | -0.46 | ||||
| Current Valuation | 434.76 K | ||||
| Shares Outstanding | 1.5 M | ||||
| Number Of Shares Shorted | 47.72 K | ||||
| Price To Earning | (0.01) X | ||||
| Price To Book | 0.1 X | ||||
| EBITDA | (13.04 M) | ||||
| Net Income | (30.05 M) | ||||
| Cash And Equivalents | 1.98 M | ||||
| Cash Per Share | 1.32 X | ||||
| Total Debt | 1.57 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 0.76 X | ||||
| Book Value Per Share | 2.08 X | ||||
| Cash Flow From Operations | (24.28 M) | ||||
| Short Ratio | 2.56 X | ||||
| Earnings Per Share | (3.79) X | ||||
| Target Price | 1.0 | ||||
| Beta | 0.9 | ||||
| Market Capitalization | 29 | ||||
| Total Asset | 11.64 M | ||||
| Retained Earnings | (438.94 M) | ||||
| Working Capital | 3.6 M | ||||
| Current Asset | 5.22 M | ||||
| Current Liabilities | 1.62 M | ||||
| Z Score | -55.1 | ||||
| Net Asset | 11.64 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Poniard Pink Sheet
If you are still planning to invest in Poniard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poniard Pharmaceuticals' history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |